# US 2024/0245547 A1 · Intravaginal ring devices

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2024/0245547 A1
- Document ID: US20240245547A1
- Status: Published application
- Kind: A1
- Application number: 18/561,377
- Filed: 2022-05-25
- Published: 2024-07-25
- Earliest claimed: 2019-11-18
- Assignees: Daré Bioscience, Inc.
- Applicants: Daré Bioscience, Inc.
- Inventors: David Friend; Jennifer Kiang; Nicolas Pacelli; Mark Walters
- Web page: https://patentgrep.com/patent/US20240245547A1

## CPC

- A61F 6/08: Pessaries, i.e. devices worn in the vagina to support the uterus, remedy a malposition or prevent conception {, e.g. combined with devices protecting against contagion}
- A61K 9/0036: {Devices retained in the vagina or cervix for a prolonged period, e.g. intravaginal rings, medicated tampons, medicated diaphragms}
- A61F 6/06: for use by females (A61F6/20 takes precedence)
- A61K 31/375: Ascorbic acid, i.e. vitamin C; Salts thereof
- A61K 31/4985: Pyrazines or piperazines ortho- or peri-condensed with heterocyclic ring systems
- A61K 31/75: of ethene
- A61K 31/76: of vinyl chloride
- A61K 33/26: Iron; Compounds thereof
- A61K 33/34: Copper; Compounds thereof
- A61K 47/22: Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
- C08L 23/06: Polyethylene
- C08L 23/12: Polypropene
- C08L 31/04: Homopolymers or copolymers of vinyl acetate
- A61F: FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS (dental prosthetics A61C)
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)
- C08L: COMPOSITIONS OF MACROMOLECULAR COMPOUNDS (compositions based on polymerisable monomers C08F, C08G; artificial filaments or fibres D01F; textile treating compositions D06)

## Abstract

Disclosed herein are intravaginal ring (IVR) devices comprising barriers that may be metal, polymeric or combinations of metal and polymeric. The IVRs are useful for contraception, treating and/or preventing sexually transmitted diseases, and treating and/or preventing bacterial infections. The IVR's are resistant to distortion due to absorption of vaginal fluids. This allows the IVRs to perform better over time as compared to other intravaginal rings made with copolymeric silicone.

## Claims

### Claim 1

An intravaginal ring device comprising a flat, circular or oval ring made with a non-segmented or segmented uncoated thermoplastic elastomer, excluding copolymeric silicone, wherein the ring contains one or more active ingredients; and, wherein the ring encircles a curved or flat, non-resorbable metal barrier, polymeric barrier, combination metal and polymer barrier or a barrier made with perforated film, wherein the barrier is attached to the ring and the barrier is not fully occlusive to allow the passage of uterine secretions.

### Claim 2 (depends on 1)

The intravaginal ring device according to claim 1, wherein the uncoated thermoplastic elastomer is selected from one or more of styrene-butadiene block copolymer, ethylene vinyl acetate copolymer, poly(methyl methacrylate), poly(butyl methacrylate), poly(vinylchloride), nylon, plasticized soft nylon, poly(ethylene terephthalate) (PET), poly(ethylene), poly(acrylonitrile), polychlorotrifluoroethylene (PCTFE), poly(ethylene-vinyl esters), poly(ethylene-vinyl acetate), poly(vinylchloride-diethyl fumarate), poly(esters of acrylic and methacrylic), poly(amides), poly(vinyl chloride), PTFE (polytetrafluoroethylene) poly(urethane), polypropylene or other poly(olefins).

### Claim 3 (depends on 2)

The intravaginal device according to claim 2, wherein the uncoated thermoplastic elastomer is selected from ethylene vinyl acetate copolymer, polyurethane, or PET.

### Claim 4 (depends on 3)

The intravaginal ring device according to claim 3, wherein the uncoated thermoplastic elastomer is ethylene vinyl acetate copolymer.

### Claim 5 (depends on 1, 2, 3, 4)

The intravaginal ring device according to any one of claims 1-4, wherein the polymeric barrier is a mesh comprised of one or more of polyolefin, nylon, and/or silk.

### Claim 6 (depends on 5)

The intravaginal ring device of claim 5, wherein the polyolefin is polypropylene or polyethylene.

### Claim 7 (depends on 1, 2, 3, 4, 5, 6)

The intravaginal ring device according to any one of claims 1-6 wherein the polymeric mesh is a mono- or multi-filament polymer.

### Claim 8 (depends on 7)

The intravaginal ring device according to claim 7, wherein the polymeric barrier or mesh comprises one or more spermiostatic metals and/or metal salts as active ingredients.

### Claim 9 (depends on 8)

The intravaginal ring device according to claim 8, wherein the metal salt is selected from one or more of calcium chloride, magnesium chloride, ferrous sulfate, ferrous gluconate, iron amino acid chelates, copper sulfate, copper gluconate, silver nitrite, copper amino acid chelates, and copper oxide.

### Claim 10 (depends on 1, 2, 3, 4)

The intravaginal ring device according to any one of claims 1-4, wherein the barrier is metal and comprises one or more of aluminum, copper, stainless steel, titanium, nickel, nickel-titanium, gold, silver, platinum or palladium.

### Claim 11

The intravaginal ring device according to 10, wherein the metal barrier is a mono- and/or multi-filament metal barrier.

### Claim 12 (depends on 11)

The intravaginal ring device according to claim 11, wherein the metal barrier comprises one or more spermiostatic metals.

### Claim 13 (depends on 12)

The intravaginal ring device according to claim 12, wherein the metal is copper and/or silver.

### Claim 14 (depends on 1, 2, 3, 4)

The intravaginal ring device according to any one of claims 1-4, wherein the barrier is a combination of metal and a polymer barrier which is attached to the ring.

### Claim 15 (depends on 14)

The intravaginal ring device according to claim 14, wherein the polymeric barrier is a mesh comprised of one or more of polyolefin, nylon, and/or silk.

### Claim 16 (depends on 15)

The intravaginal ring device of claim 15, wherein the polyolefin is polypropylene or polyethylene.

### Claim 17 (depends on 15, 16)

The intravaginal ring device according to any one of claim 15 or 16 wherein the polymeric mesh is a mono- or multi-filament polymer.

### Claim 18 (depends on 14, 15, 16, 17)

The intravaginal ring device according to any one of claims 14-17, wherein the metal portion of the barrier comprises one or more of aluminum, copper, stainless steel, titanium, nickel, nickel-titanium, gold, silver, platinum or palladium.

### Claim 19

The intravaginal ring device according to 18, wherein the metal barrier is a mono- and/or multi-filament metal barrier.

### Claim 20 (depends on 14, 15, 16, 17, 18, 19)

The intravaginal ring device according to claims 14-19, wherein the metal and/or polymeric portion of the barrier comprises one or more spermiostatic metals and/or metal salts as active ingredients.

### Claim 21 (depends on 20)

The intravaginal ring device according to claim 20, wherein the metal is copper and/or silver, and the metal salt is selected from one or more of calcium chloride, magnesium chloride, ferrous sulfate, ferrous gluconate, iron amino acid chelates, copper sulfate, copper gluconate, silver nitrite, copper amino acid chelates, and copper oxide.

### Claim 22 (depends on 1)

The intravaginal ring device according to claim 1, wherein the barrier is a perforated film.

### Claim 23 (depends on 23)

The intravaginal ring device of claim 23 wherein the perforated film comprises multiple layers that are offset.

### Claim 24 (depends on 22, 23)

The intravaginal ring device of any one of claim 22 or 23, wherein the perforated film is made with one or more polymers selected from 1,2-polybutadiene, ethylene vinyl acetate, polyethylene, silicone gel, or polyurethane.

### Claim 25 (depends on 22, 23, 24)

The intravaginal ring device of any one of claims 22-24, wherein the perforated film comprises one or more spermiostatic metals and/or metal salts as active ingredients.

### Claim 26 (depends on 25)

The intravaginal ring device according to claim 25, wherein the metal salt is selected from one or more of calcium chloride, magnesium chloride, ferrous sulfate, ferrous gluconate, iron amino acid chelates, copper sulfate, copper gluconate, silver nitrite, copper amino acid chelates, and copper oxide.

### Claim 27 (depends on 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26)

The intravaginal ring device according to any one of claims 1-26, wherein the ring further comprises ascorbic acid.

### Claim 28 (depends on 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27)

The intravaginal ring device according to any one of claims 1-27, further comprising a removal tab, tag or string.

### Claim 29 (depends on 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28)

The intravaginal ring device according to any one of claims 1-28, wherein the ring contains two or more segments.

### Claim 30 (depends on 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29)

The intravaginal ring of any one of claims 1-29, wherein the ring further comprises an active agent to prevent pregnancy, and/or to treat or prevent bacterial infections, and viral infections.

### Claim 31 (depends on 30)

The intravaginal ring of claim 30 wherein the active agent is a non-hormonal or hormonal contraceptive, and the antiviral agent is used to treat or prevent one or more sexually transmitted diseases.

### Claim 32 (depends on 31)

The intravaginal ring of claim 31, wherein the antiviral agent is one or more of tenofovir, atanzanavir, darunavir, fos/amprenavir, indinavir, lopinavir, nelfinavir, ritonavir, saquinavir, tipranavir, efavirenz, or nelfinavir;

### Claim 33 (depends on 31)

The intravaginal ring of claim 31, wherein the hormonal contraceptives is one or more of desogestrel, drospirenone, ethinyl estradiol, levonorgestrel, medroxyprogesterone acetate, norelgestromin, norethindrone, norgestimate, or norgestrel.

### Claim 34

The intravaginal ring of any one of 30-33, wherein the intravaginal ring further comprises active ingredients contained in discrete reservoirs and/or continuous sheathed in a polymer as part of the uncoated thermoplastic elastomer.

### Claim 35 (depends on 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34)

The intravaginal ring device according to any one of claims 1-34 wherein the intravaginal ring has less distortion after storage or after insertion into a subject for at least 14 days when compared to an intravaginal ring device made with a copolymeric silicone matrix in which both rings contain equivalent amounts and composition of nonhormonal spermiostatic agents and/or ascorbic acid if present.

### Claim 36

An intravaginal ring device comprising a saddle-shaped, oval ring made with a non-segmented or segmented uncoated thermoplastic elastomer, excluding copolymeric silicone, wherein the ring contains one or more active ingredients; and, wherein the ring encircles a curved, non-resorbable metal barrier, polymeric barrier, combination metal and polymer barrier or a barrier made with perforated film, wherein the barrier is attached to the ring and the barrier is not fully occlusive to allow the passage of uterine secretions.

### Claim 37 (depends on 36)

The intravaginal ring device according to claim 36, wherein the thermoplastic elastomer is selected from one or more of styrene-butadiene block copolymer, ethylene vinyl acetate copolymer, poly(methyl methacrylate), poly(butyl methacrylate), poly(vinylchloride), nylon, soft nylon, poly(ethylene terephthalate) (PET), poly(ethylene), poly(acrylonitrile), PCTFE, poly(ethylene-vinyl esters), poly(ethylene-vinyl acetate), poly(vinylchloride-diethyl fumarate), poly(esters of acrylic and methacrylic), poly(amides), poly(vinyl chloride), PTFE (polytetrafluoroethylene) poly(urethane), polypropylene or other poly(olefins).

### Claim 38 (depends on 37)

The intravaginal device according to claim 37, wherein the thermoplastic elastomer is selected from ethylene vinyl acetate copolymer, polyurethane, or PET.

### Claim 39 (depends on 38)

The intravaginal ring device according to claim 38, wherein the uncoated thermoplastic elastomer is ethylene vinyl acetate copolymer.

### Claim 40 (depends on 36, 37, 38, 39)

The intravaginal ring device according to any one of claims 36-39, wherein the polymeric barrier is a mesh comprised of one or more polyolefin, nylon, and/or silk.

### Claim 41 (depends on 40)

The intravaginal ring device of claim 40, wherein the polyolefin is polypropylene or polyethylene.

### Claim 42 (depends on 36, 37, 38, 39, 40, 41)

The intravaginal ring device according to any one of claims 36-41, wherein the polymeric mesh is a mono- or multi-filament polymer.

### Claim 43 (depends on 42)

The intravaginal ring device according to claim 42, wherein the ring contains one or more spermiostatic metals and/or metal salts as active agents.

### Claim 44 (depends on 43)

The intravaginal ring device according to claim 43, wherein the spermiostatic metals and or metal salts are selected from one or more of calcium chloride, magnesium chloride, ferrous sulfate, ferrous gluconate, iron amino acid chelates, copper sulfate, copper gluconate, silver nitrite, copper amino acid chelates, and copper oxide.

### Claim 45 (depends on 36, 37, 38, 39)

The intravaginal ring device according to any one of claims 36-39, wherein the barrier is metal and comprises one or more of aluminum, copper, stainless steel, titanium, nickel, nickel-titanium, gold, silver, platinum or palladium.

### Claim 46 (depends on 45)

The intravaginal ring device according to claim 45, wherein the metal barrier is a mono- and/or multi-filament.

### Claim 47 (depends on 46)

The intravaginal ring device according to claim 46, wherein the metal barrier comprises one or more spermiostatic metals as active agents.

### Claim 48 (depends on 47)

The intravaginal ring device according to claim 47, wherein the spermiostatic metal is copper and/or silver.

### Claim 49 (depends on 36, 37, 38, 39)

The intravaginal ring device according to any one of claims 36-39, wherein the barrier is a combination of one or more metals and one or more polymers wherein the barrier is attached to the ring.

### Claim 50 (depends on 49)

The intravaginal ring device according to claim 49, wherein the polymeric barrier portion of the barrier is a mesh comprised of one or more polyolefin, nylon, and/or silk.

### Claim 51 (depends on 50)

The intravaginal ring device of claim 50, wherein the polyolefin is polypropylene or polyethylene.

### Claim 52 (depends on 50, 51)

The intravaginal ring device according to any one of claim 50 or 51, wherein the polymeric mesh is a mono- or multi-filament polymer.

### Claim 53 (depends on 49, 50, 51, 52)

The intravaginal ring device according to any one of claims 49-52, wherein the metal portion of the barrier comprises a metal selected from one or more of aluminum, copper, stainless steel, titanium, nickel, nickel-titanium, gold, silver, platinum or palladium.

### Claim 54 (depends on 53)

The intravaginal ring device according to claim 53, wherein the metal barrier is a mono- and/or multi-filament.

### Claim 55 (depends on 49, 50, 51, 52, 53, 54)

The intravaginal ring device according to claims 49-54, wherein the metal and/or polymeric portion of the barrier comprises one or more spermiostatic metals or and/or metal salts as active ingredients.

### Claim 56 (depends on 55)

The intravaginal ring device according to claim 55, wherein the metal is copper and/or silver and the metal salt is selected from one or more of calcium chloride, magnesium chloride, ferrous sulfate, ferrous gluconate, iron amino acid chelates, copper sulfate, copper gluconate, silver nitrite, copper amino acid chelates, and copper oxide.

### Claim 57 (depends on 36)

The intravaginal ring device according to claim 36, wherein the barrier is a perforated film.

### Claim 58 (depends on 57)

The intravaginal ring device of claim 57 wherein the perforated film comprises multiple layers that are offset.

### Claim 59 (depends on 57, 58)

The intravaginal ring device of any one of claim 57 or 58, wherein the perforated film is made with one or more polymers selected from 1,2-polybutadiene, ethylene vinyl acetate, polyethylene, silicone gel, or polyurethane.

### Claim 60 (depends on 59)

The intravaginal ring device of any one of claim 59, wherein the perforated film comprises one or more spermiostatic metal or metal salts as active ingredients.

### Claim 61 (depends on 60)

The intravaginal ring device according to claim 60, wherein the metal is copper and/or silver and the metal salt is selected from one or more of calcium chloride, magnesium chloride, ferrous sulfate, ferrous gluconate, iron amino acid chelates, copper sulfate, copper gluconate, silver nitrite, copper amino acid chelates, and copper oxide.

### Claim 62 (depends on 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56)

The intravaginal ring device according to any one of claims 36-56, wherein the intravaginal ring device further comprises ascorbic acid.

### Claim 63 (depends on 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57, 58, 59, 60, 61, 62)

The intravaginal ring device according to any one of claims 36-62, further comprising a removal tab, tag or string.

### Claim 64 (depends on 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57, 58, 59, 60, 61, 62, 63)

The intravaginal ring device according to any one of claims 36-63, wherein the ring contains two or more segments.

### Claim 65 (depends on 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57, 58, 59, 60, 61, 62, 63, 64)

The intravaginal ring device of any one of claims 36-64, further comprising an active agent in the ring portion to prevent pregnancy, and/or to treat or prevent bacterial infections, or viral infections.

### Claim 66 (depends on 59)

The intravaginal ring of claim 59 wherein the active agent to prevent pregnancy is a hormonal contraceptive, and the antiviral agent prevents one or more sexually transmitted infections.

### Claim 67 (depends on 65, 66)

The intravaginal ring of any one of claim 65 or 66, wherein the antiviral agent is one or more of tenofovir, atanzanavir, darunavir, fos/amprenavir, indinavir, lopinavir, nelfinavir, ritonavir, saquinavir, tipranavir, efavirenz, or nelfinavir;

### Claim 68 (depends on 65, 66)

The intravaginal ring of any one of claim 65 or 66, wherein the hormonal contraceptives is one or more of desogestrel, drospirenone, ethinyl estradiol, levonorgestrel, medroxyprogesterone acetate, norelgestromin, norethindrone, norgestimate, or norgestrel.

### Claim 69

The intravaginal ring of any one of 65-68, wherein the intravaginal ring further comprises active ingredients contained in discrete reservoirs and/or continuous sheathed in a polymer as part of the thermoplastic elastomer.

### Claim 70

The intravaginal ring device according to any one of 34-69 wherein the intravaginal ring has less distortion after storage or after insertion into a subject for at least 14 days when compared to an intravaginal ring device made with a copolymeric silicone matrix in which both rings contain equivalent amounts and composition of nonhormonal spermiostatic agents and/or ascorbic acid if present.

### Claim 71

An intravaginal ring device comprising a flat, circular or oval ring made with a non-segmented or segmented uncoated thermoplastic elastomer, excluding copolymeric silicone, wherein the ring encircles a curved or flat, non-resorbable metal barrier, polymeric barrier, combination metal and polymer barrier or a barrier made with perforated film, wherein the barrier is attached to the ring and said metal and polymer barriers and said perforated film contain active ingredients; wherein said barriers or perforated film is not fully occlusive to allow the passage of uterine secretions.

### Claim 72 (depends on 71)

The intravaginal ring device according to claim 71, wherein the uncoated thermoplastic elastomer is selected from one or more of styrene-butadiene block copolymer, ethylene vinyl acetate copolymer, poly(methyl methacrylate), poly(butyl methacrylate), poly(vinylchloride), nylon, plasticized soft nylon, poly(ethylene terephthalate) (PET), poly(ethylene), poly(acrylonitrile), polychlorotrifluoroethylene (PCTFE), poly(ethylene-vinyl esters), poly(ethylene-vinyl acetate), poly(vinylchloride-diethyl fumarate), poly(esters of acrylic and methacrylic), poly(amides), poly(vinyl chloride), PTFE (polytetrafluoroethylene) poly(urethane), polypropylene or other poly(olefins).

### Claim 73 (depends on 72)

The intravaginal device according to claim 72, wherein the uncoated thermoplastic elastomer is selected from ethylene vinyl acetate copolymer, polyurethane, or PET.

### Claim 74 (depends on 73)

The intravaginal ring device according to claim 73, wherein the uncoated thermoplastic elastomer is ethylene vinyl acetate copolymer.

### Claim 75 (depends on 71, 72, 73, 74)

The intravaginal ring device according to any one of claims 71-74, wherein the polymeric barrier is a mesh comprised of one or more of polyolefin, nylon, and/or silk.

### Claim 76 (depends on 75)

The intravaginal ring device of claim 75, wherein the polyolefin is polypropylene or polyethylene.

### Claim 77 (depends on 71, 72, 73, 74, 75, 76)

The intravaginal ring device according to any one of claims 71-76 wherein the polymeric mesh is a mono- or multi-filament polymer.

### Claim 78 (depends on 77)

The intravaginal ring device according to claim 77, wherein the polymeric barrier or mesh comprises one or more metal salts as active ingredients.

### Claim 79 (depends on 78)

The intravaginal ring device according to claim 78, wherein the metal salt is selected from one or more of calcium chloride, magnesium chloride, ferrous sulfate, ferrous gluconate, iron amino acid chelates, copper sulfate, copper gluconate, silver nitrite, copper amino acid chelates, and copper oxide.

### Claim 80 (depends on 71, 72, 73, 74)

The intravaginal ring device according to any one of claims 71-74, wherein the barrier is metal and the barrier comprises one or more of aluminum, copper, stainless steel, titanium, nickel, nickel-titanium, gold, silver, platinum or palladium.

### Claim 81

The intravaginal ring device according to 80, wherein the metal barrier is a mono- and/or multi-filament metal barrier.

### Claim 82 (depends on 81)

The intravaginal ring device according to claim 81, wherein the metal barrier comprises one or more spermiostatic metals as active ingredients.

### Claim 83 (depends on 82)

The intravaginal ring device according to claim 82, wherein the metal is copper and/or silver.

### Claim 84 (depends on 71, 72, 73, 74)

The intravaginal ring device according to any one of claims 71-74, wherein the barrier is a combination of metal and a polymer barrier which is attached to the ring.

### Claim 85 (depends on 84)

The intravaginal ring device according to claim 84, wherein the polymeric barrier portion is a mesh comprised of one or more polyolefin, nylon, and/or silk.

### Claim 86 (depends on 85)

The intravaginal ring device of claim 85, wherein the polyolefin is polypropylene or polyethylene.

### Claim 87 (depends on 85, 86)

The intravaginal ring device according to any one of claim 85 or 86, wherein the polymeric mesh is a mono- or multi-filament polymer.

### Claim 88 (depends on 84, 85, 86, 87, 88)

The intravaginal ring device according to any one of claims 84-88, wherein the metal portion of the barrier comprises one or more of aluminum, copper, stainless steel, titanium, nickel, nickel-titanium, gold, silver, platinum or palladium.

### Claim 89 (depends on 88)

The intravaginal ring device according to claim 88, wherein the metal barrier is a mono- or multi-filament polymer.

### Claim 90 (depends on 84, 85, 86, 87, 88, 89)

The intravaginal ring device according to claims 84-89, wherein the metal and/or polymeric portion of the barrier comprises one or more spermiostatic metals and/or metal salts as active ingredients.

### Claim 91 (depends on 90)

The intravaginal ring device according to claim 90, wherein the metal is copper and/or silver and the metal salt is selected from one or more of calcium chloride, magnesium chloride, ferrous sulfate, ferrous gluconate, iron amino acid chelates, copper sulfate, copper gluconate, silver nitrite, copper amino acid chelates, and copper oxide.

### Claim 92 (depends on 71, 72, 73, 74)

The intravaginal ring device according to claim 71-74, wherein the barrier is a perforated film.

### Claim 93 (depends on 92)

The intravaginal ring device of claim 92 wherein the perforated film comprises multiple layers that are offset.

### Claim 94 (depends on 92, 93)

The intravaginal ring device of any one of claim 92 or 93, wherein the perforated film is made with polymers selected from 1,2-polybutadiene, ethylene vinyl acetate, polyethylene, silicone gel, or polyurethane.

### Claim 95 (depends on 92, 93, 94)

The intravaginal ring device of any one of claims 92-94, wherein the perforated film comprises one or more spermiostatic metals and/or metal salts as active ingredients.

### Claim 96 (depends on 95)

The intravaginal ring device according to claim 95, wherein the metal salt is selected from one or more of calcium chloride, magnesium chloride, ferrous sulfate, ferrous gluconate, iron amino acid chelates, copper sulfate, copper gluconate, silver nitrite, copper amino acid chelates, and copper oxide.

### Claim 97 (depends on 71, 72, 73, 74, 75, 76, 77, 78, 79, 80, 81, 82, 83, 84, 85, 86, 87, 88, 89, 90, 91, 92, 93, 94, 95, 96)

The intravaginal ring device according to any one of claims 71-96, wherein the intravaginal ring further comprises ascorbic acid.

### Claim 98 (depends on 71, 72, 73, 74, 75, 76, 77, 78, 79, 80, 81, 82, 83, 84, 85, 86, 87, 88, 89, 90, 91, 92, 93, 94, 95, 96, 97)

The intravaginal ring device according to any one of claims 71-97, further comprising a removal tab, tag or string.

### Claim 99 (depends on 71, 72, 73, 74, 75, 76, 77, 78, 79, 80, 81, 82, 83, 84, 85, 86, 87, 88, 89, 90, 91, 92, 93, 94, 95, 96, 97, 98)

The intravaginal ring device according to any one of claims 71-98, wherein the ring contains two or more segments.

### Claim 100

The intravaginal ring device according to any one of 71-99 wherein the intravaginal ring has less distortion after storage or after insertion into a subject for at least 14 days when compared to an intravaginal ring device made with a copolymeric silicone matrix in which both rings contain equivalent amounts and composition of nonhormonal spermiostatic agents and/or ascorbic acid if present.

### Claim 101

An intravaginal ring device comprising a saddle-shaped, oval ring made with a non-segmented or segmented uncoated thermoplastic elastomer, excluding copolymeric silicone, wherein the ring encircles a curved or flat, non-resorbable metal barrier, polymeric barrier, combination metal and polymer barrier or a barrier made with perforated film, wherein the barrier is attached to the ring and said metal and polymer barriers and said perforated film optionally contain active ingredients; wherein said barriers or perforated film is not fully occlusive to allow the passage of uterine secretions.

### Claim 102 (depends on 101)

The intravaginal ring device according to claim 101, wherein the thermoplastic elastomer is selected from one or more of styrene-butadiene block copolymer, ethylene vinyl acetate copolymer, poly(methyl methacrylate), poly(butyl methacrylate), poly(vinylchloride), nylon, soft nylon, poly(ethylene terephthalate) (PET), poly(ethylene), poly(acrylonitrile), PCTFE, poly(ethylene-vinyl esters), poly(ethylene-vinyl acetate), poly(vinylchloride-diethyl fumarate), poly(esters of acrylic and methacrylic), poly(amides), poly(vinyl chloride), PTFE (polytetrafluoroethylene) poly(urethane), polypropylene or other poly(olefins).

### Claim 103 (depends on 102)

The intravaginal device according to claim 102, wherein the uncoated thermoplastic elastomer is selected from ethylene vinyl acetate copolymer, polyurethane, or PET.

### Claim 104 (depends on 103)

The intravaginal ring device according to claim 103, wherein the uncoated thermoplastic elastomer is ethylene vinyl acetate copolymer.

### Claim 105 (depends on 101, 102, 103, 104)

The intravaginal ring device according to claim any one of claims 101-104, wherein the polymeric barrier is a mesh comprised of one or more polyolefin, nylon, and/or silk.

### Claim 106 (depends on 105)

The intravaginal ring device of claim 105, wherein the polyolefin is polypropylene or polyethylene.

### Claim 107 (depends on 101, 102, 103, 104, 105, 106)

The intravaginal ring device according to any one of claims 101-106, wherein the polymeric mesh is a mono- or multi-filament polymer.

### Claim 108 (depends on 107)

The intravaginal ring device according to claim 107, wherein the polymeric mesh contains one or more spermiostatic metal salts as active ingredients.

### Claim 109 (depends on 99)

The intravaginal ring device according to claim 99, wherein the spermiostatic metal salts are selected from one or more of calcium chloride, magnesium chloride, ferrous sulfate, ferrous gluconate, iron amino acid chelates, copper sulfate, copper gluconate, silver nitrite, copper amino acid chelates, and copper oxide.

### Claim 110 (depends on 101, 102, 103, 104)

The intravaginal ring device according to any one of claims 101-104, wherein the barrier is metal comprising one or more of aluminum, copper, stainless steel, titanium, nickel, nickel-titanium, gold, silver, platinum or palladium.

### Claim 111 (depends on 110)

The intravaginal ring device according to claim 110, wherein the metal barrier is a mono- and/or multi-filament.

### Claim 112 (depends on 111)

The intravaginal ring device according to claim 111, wherein the metal barrier comprises one or more spermiostatic metals as active ingredients.

### Claim 113 (depends on 112)

The intravaginal ring device according to claim 112, wherein the metal is copper and/or silver.

### Claim 114 (depends on 101, 102, 103, 104)

The intravaginal ring device according to any one of claims 101-104, wherein the barrier is a combination of one or more metals and one or more polymers wherein the barrier is attached to the ring.

### Claim 115 (depends on 114)

The intravaginal ring device according to claim 114, wherein the polymeric barrier portion of the barrier is a mesh comprised of one or more polyolefin, nylon, and/or silk.

### Claim 116 (depends on 115)

The intravaginal ring device of claim 115, wherein the polyolefin is polypropylene or polyethylene.

### Claim 117 (depends on 115, 116)

The intravaginal ring device according to any one of claims 115-116, wherein the polymeric mesh is a mono- or multi-filament polymer.

### Claim 118 (depends on 114, 115, 116, 117)

The intravaginal ring device according to any one of claims 114-117, wherein the metal portion of the barrier comprises a metal selected from one or more of aluminum, copper, stainless steel, titanium, nickel, nickel-titanium, gold, silver, platinum or palladium.

### Claim 119 (depends on 118)

The intravaginal ring device according to claim 118, wherein the metal barrier is a mono- and/or multi-filament.

### Claim 120 (depends on 114, 115, 116, 117, 118, 119)

The intravaginal ring device according to claims 114-119, wherein the metal and/or polymeric portion of the barrier comprises one or more spermiostatic metals and/or metal salts as active ingredients.

### Claim 121 (depends on 110)

The intravaginal ring device according to claim 110, wherein the metal is copper and/silver and the metal salt is selected from one or more of calcium chloride, magnesium chloride, ferrous sulfate, ferrous gluconate, iron amino acid chelates, copper sulfate, copper gluconate, silver nitrite, copper amino acid chelates, and copper oxide.

### Claim 122 (depends on 101, 102, 103, 104)

The intravaginal ring device according to claim 101-104, wherein the barrier is a perforated film.

### Claim 123 (depends on 122)

The intravaginal ring device of claim 122 wherein the perforated film comprises multiple layers that are offset.

### Claim 124 (depends on 122, 123)

The intravaginal ring device of any one of claim 122 or 123, wherein the perforated film is made with polymers selected from 1,2-polybutadiene, ethylene vinyl acetate, polyethylene, silicone gel, or polyurethane.

### Claim 125 (depends on 122, 123, 124)

The intravaginal ring device of any one of claims 122-124, wherein the perforated film comprises one or more spermiostatic metals and/or metal salts as active ingredients.

### Claim 126 (depends on 125)

The intravaginal ring device according to claim 125, wherein the metal salt is selected from one or more of calcium chloride, magnesium chloride, ferrous sulfate, ferrous gluconate, iron amino acid chelates, copper sulfate, copper gluconate, silver nitrite, copper amino acid chelates, and copper oxide.

### Claim 127 (depends on 101, 102, 103, 104, 105, 106, 107, 108, 109, 110, 111, 112, 113, 114, 115, 116, 117, 118, 119, 120, 121, 122, 123, 124, 125, 126)

The intravaginal ring device according to any one of claims 101-126, wherein the intravaginal ring further comprises ascorbic acid.

### Claim 128 (depends on 101, 102, 103, 104, 105, 106, 107, 108, 109, 110, 111, 112, 113, 114, 115, 116, 117, 118, 119, 120, 121, 122, 123, 124, 125, 126, 127)

The intravaginal ring device according to any one of claims 101-127, further comprising a removal tab, tag or string.

### Claim 129 (depends on 101, 102, 103, 104, 105, 106, 107, 108, 109, 110, 111, 112, 113, 114, 115, 116, 117, 118, 119, 120, 121, 122, 123, 124, 125, 126, 127, 128)

The intravaginal ring device according to any one of claims 101-128, wherein the ring contains two or more segments.

### Claim 130

The intravaginal ring device according to any one of 101-129 wherein the intravaginal ring has less distortion after storage or after insertion into a subject for at least 14 days when compared to an intravaginal ring device made with a copolymeric silicone matrix in which both rings contain equivalent amounts and composition of nonhormonal spermiostatic agents and/or ascorbic acid if present.

### Claim 131

An intravaginal ring device comprising a flat, circular or oval ring made with a non-segmented uncoated thermoplastic elastomer, excluding copolymeric silicone, wherein the ring contains one or more non-hormonal spermiostatic agents; and, wherein the ring encircles a curved, non-resorbable polymeric barrier which is attached to the ring; and wherein the ring covers the cervix when inserted into a subject.

### Claim 132 (depends on 131)

The intravaginal ring device according to claim 131, wherein the uncoated thermoplastic elastomer is selected from one or more of styrene-butadiene block copolymer, ethylene vinyl acetate copolymer, poly(methyl methacrylate), poly(butyl methacrylate), poly(vinylchloride), nylon, plasticized soft nylon, poly(ethylene terephthalate) (PET), poly(ethylene), poly(acrylonitrile), polychlorotrifluoroethylene (PCTFE), poly(ethylene-vinyl esters), poly(ethylene-vinyl acetate), poly(vinylchloride-diethyl fumarate), poly(esters of acrylic and methacrylic), poly(amides), poly(vinyl chloride), PTFE (polytetrafluoroethylene) poly(urethane), polypropylene or other poly(olefins).

### Claim 133 (depends on 132)

The intravaginal device according to claim 132, wherein the uncoated thermoplastic elastomer is selected from ethylene vinyl acetate copolymer, polyurethane, or PET.

### Claim 134 (depends on 133)

The intravaginal ring device according to claim 133, wherein the uncoated thermoplastic elastomer is ethylene vinyl acetate copolymer.

### Claim 135 (depends on 131, 132, 133, 134)

The intravaginal ring device according to any one of claims 131-134, wherein the polymeric barrier is a mesh comprised of one or more polyolefin, nylon, and/or silk.

### Claim 136 (depends on 135)

The intravaginal ring device of claim 135, wherein the polyolefin is polypropylene or polyethylene.

### Claim 137 (depends on 131, 132, 133, 134, 135, 136)

The intravaginal ring device according to any one of claims 131-136 wherein the mesh or barrier is a mono- or multi-filament polymer.

### Claim 138 (depends on 131, 132, 133, 134, 135, 136, 137)

The intravaginal ring device according to any one of claims 131-137, wherein the ring contains one or more spermiostatic metals and/or metal salts.

### Claim 139 (depends on 138)

The intravaginal ring device according to claim 138, wherein the ring contains spermiostatic metals and/or salts selected from one or more of ferrous sulfate, ferrous gluconate, iron amino acid chelates, copper sulfate, copper gluconate, copper amino acid chelates, and copper oxide.

### Claim 140 (depends on 139)

The intravaginal ring device according to claim 139, wherein the ring further comprises ascorbic acid.

### Claim 141 (depends on 140)

The intravaginal ring device according to claim 140, further comprising a removal tab.

### Claim 142 (depends on 131, 132, 133, 134, 135, 136, 137, 138, 139, 140, 141)

The intravaginal ring device according to any one of claims 131-141 wherein the intravaginal ring has less distortion after storage or after insertion into a subject for at least 14 days when compared to an intravaginal ring device made with a copolymeric silicone matrix in which both rings contain equivalent amounts and composition of nonhormonal spermiostatic agents and/or ascorbic acid if present.

### Claim 143

An intravaginal ring device comprising a saddle-shaped, oval ring made with a non-segmented uncoated thermoplastic elastomer, excluding copolymeric silicone, wherein the ring contains one or more non-hormonal spermiostatic agents; and, wherein the ring encircles a curved, non-resorbable polymeric barrier which is attached to the ring; and wherein the ring covers the cervix.

### Claim 144 (depends on 143)

The intravaginal ring device according to claim 143, wherein the thermoplastic elastomer is selected from one or more of styrene-butadiene block copolymer, ethylene vinyl acetate copolymer, poly(methyl methacrylate), poly(butyl methacrylate), poly(vinylchloride), nylon, soft nylon, poly(ethylene terephthalate) (PET), poly(ethylene), poly(acrylonitrile), PCTFE, poly(ethylene-vinyl esters), poly(ethylene-vinyl acetate), poly(vinylchloride-diethyl fumarate), poly(esters of acrylic and methacrylic), poly(amides), poly(vinyl chloride), PTFE (polytetrafluoroethylene) poly(urethane), polypropylene or other poly(olefins).

### Claim 145 (depends on 144)

The intravaginal device according to claim 144, wherein the thermoplastic elastomer is selected from ethylene vinyl acetate copolymer, polyurethane, or PET.

### Claim 146 (depends on 145)

The intravaginal ring device according to claim 145, wherein the uncoated thermoplastic elastomer is ethylene vinyl acetate copolymer.

### Claim 147 (depends on 143, 144, 145, 146)

The intravaginal ring device according to claim any one of claims 143-146, wherein the barrier is a mesh comprised of one or more polyolefin, nylon, and/or silk.

### Claim 148 (depends on 147)

The intravaginal ring device of claim 147, wherein the polyolefin is polypropylene or polyethylene.

### Claim 149 (depends on 143, 144, 145, 146, 147, 148)

The intravaginal ring device according to claims any one of claims 143-148, wherein the mesh and/or barrier is a mono- or multi-filament polymer.

### Claim 150 (depends on 143, 144, 145, 146, 147, 148, 149)

The intravaginal ring device according to any one of claims 143-149, wherein the ring contains one or more spermiostatic metals and/or metal salts.

### Claim 151 (depends on 150)

The intravaginal ring device according to claim 150, wherein the spermiostatic metals and or metal salts are selected from one or more of ferrous sulfate, ferrous gluconate, iron amino acid chelates, copper sulfate, copper gluconate, copper amino acid chelates, copper oxide.

### Claim 152

The intravaginal ring device according to claims any one of 143-151 wherein the intravaginal ring has less distortion after storage or after insertion into a subject for at least 14 days when compared to an intravaginal ring device made with a copolymeric silicone matrix in which both rings contain equivalent amounts and composition of nonhormonal spermiostatic agents and/or ascorbic acid if present.

### Claim 153

An intravaginal ring device comprising a flat, circular or oval ring made with a segmented uncoated thermoplastic elastomer, excluding copolymeric silicone, with a removal tab, wherein the ring contains one or more non-hormonal spermiostatic agents; and, wherein the ring encircles a curved, non-resorbable polymeric barrier which is attached to the ring; and wherein the ring covers the cervix when inserted into a subject.

### Claim 154 (depends on 153)

The intravaginal ring device according to claim 153, wherein the uncoated thermoplastic elastomer is selected from one or more of styrene-butadiene block copolymer, ethylene vinyl acetate copolymer, poly(methyl methacrylate), poly(butyl methacrylate), poly(vinylchloride), nylon, soft nylon, poly(ethylene terephthalate) (PET), poly(ethylene), poly(acrylonitrile), PCTFE, poly(ethylene-vinyl esters), poly(ethylene-vinyl acetate), poly(vinylchloride-diethyl fumarate), poly(esters of acrylic and methacrylic), poly(amides), poly(vinyl chloride), PTFE (polytetrafluoroethylene) poly(urethane), or polypropylene or other poly(olefins).

### Claim 155 (depends on 154)

The intravaginal ring device according to claim 154, wherein the thermoplastic elastomer is selected from ethylene vinyl acetate copolymer, polyurethane, or PET.

### Claim 156 (depends on 155)

The intravaginal ring device according to claim 155, wherein the thermoplastic elastomer is ethylene vinyl acetate copolymer.

### Claim 157 (depends on 153, 154, 155, 156)

The intravaginal ring device according to any one of claims 153-156, wherein the barrier is a mesh comprised of one or more polyolefin, nylon, and/or silk.

### Claim 158 (depends on 157)

The intravaginal ring device of claim 157, wherein the polyolefin is polypropylene or polyethylene.

### Claim 159 (depends on 153, 154, 155, 156, 157, 158)

The intravaginal ring device according to any one of claims 153-158 wherein the barrier or mesh is a mono- or multi-filament polymer.

### Claim 160 (depends on 153, 154, 155, 156, 157, 158, 159)

The intravaginal ring device according to any one of claims 153-159, wherein the intravaginal ring device contains one or more spermiostatic metals and/or metal salts.

### Claim 161 (depends on 153, 154, 155, 156, 157, 158, 159, 160)

The intravaginal ring device according to any one of claims 153-160, wherein the spermiostatic metals and or salts are selected from one or more of ferrous sulfate, ferrous gluconate, iron amino acid chelates, copper sulfate, copper gluconate, copper amino acid chelates, copper oxide.

### Claim 162 (depends on 161)

The intravaginal ring device according to claim 161, wherein one segment of the ring contains spermiostatic metals and or metal salts and another segment further comprises ascorbic acid.

### Claim 163 (depends on 153, 154, 155, 156, 157, 158, 159, 160, 161, 162)

The intravaginal device according to any one of claims 153-162, wherein the intravaginal ring has less distortion after storage or after insertion into a subject for at least a week when as compared to an intravaginal ring device with at least two segments made with a copolymeric silicone matrix in which both rings contain equivalent amounts and composition of nonhormonal spermiostatic agents and ascorbic acid.

### Claim 164 (depends on 153, 154, 155, 156, 157, 158, 159, 160, 161, 162)

The intravaginal ring device according to any one of claims 153-162 wherein the intravaginal ring has less distortion after storage in packaging containing or after insertion into a subject for at least 14 days when compared to an intravaginal ring device made with a copolymeric silicone matrix in which both rings contain equivalent amounts and composition of nonhormonal spermiostatic agents and/or ascorbic acid if present.
